Anke Wu
6 Papers
Anke Wu is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has co-authored 2 publications.
Chat about Author
Papers
Identification of molecular characteristics of hepatocellular carcinoma with microvascular invasion based on deep targeted sequencing
Linlin Zheng,Ya-Ru Wang,Zhenrong Liu,Zhi-Hao Wang,Chang-Cheng Tao,Anke Wu,Hai-Yang Li,Ting Xiao,Zhuo Li,Weiqi Rong +9 more
TL;DR: TERTp+/TP53+ was significantly enriched in MVI‐positive patients, leading to poor prognosis for HCC patients by promoting proliferation of HCC cell and inhibiting infiltration of immune cell surrounding HCC.
2
High spindle and kinetochore-associated complex subunit-3 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma.
Lin-lin Zheng,Yaru Wang,Zhen-Rong Liu,Zhi-hao Wang,Changcheng Tao,Yong-Gang Xiao,Kai Zhang,Anke Wu,Hui Li,Jianxiong Wu,Tin Xiao,Weiqi Rong +11 more
TL;DR: It is found that upregulated SKA3 expression was significantly correlated with poor prognosis in patients with HCC and may be used as a biomarker for poor prognosis and as a therapeutic target in HCC.
2
Clinical Benefits of Neoadjuvant Radiotherapy on the Postoperative Recurrence of Centrally Located Hepatocellular Carcinoma: A Real-World Evidence Based on Phase II Clinical Trial
Changcheng Tao,Fan Wu,Hongwei Wang,Liping Wang,Yu Liu,Anke Wu,Linlin Zheng,Yaru Wang,Bo Chen,Weiqi Rong,Jianxiong Wu +10 more
TL;DR: In this paper , the authors used propensity-score analysis and Cox proportional-hazards regression models to assess the sensitivity to unmeasured confounding in centrally located hepatocellular carcinoma (HCC).
1
Clinical benefits of intraoperative radiotherapy for the recurrence of centrally located hepatocellular carcinoma with microvascular invasion
Changcheng Tao,Kai Zhang,Zonggui Tao,Yue Liu,Anke Wu,Liping Wang,Qinfu Feng,Fan Wu,Weiqi Rong,Jianxiong Wu +9 more
TL;DR: IORT+LR provided safe, feasible treatment for patients with centrally located HCC with MVI, along with an improvement in prognosis and lower early recurrence rates, and appeared to be robust against unmeasured confounding factors.
1
Characterization of molecular and immune landscape of microvascular invasion in hepatocellular carcinoma and prognostic significance.
Kai Zhang,Changcheng Tao,Fan Wu,Liping Wang,Linlin Zheng,Yaru Wang,Anke Wu,Jianxiong Wu,Tin Xiao,Weiqi Rong +9 more
TL;DR: The molecular and immune landscape of MVI in HCC patients was characterized, finding MVI presence highly correlated with adverse biological markers, mutations in the promoter of TERT, and higher CD3+ TILs.